Price:

SCIENCE

Sinclair begins OSK human trials to reverse cellular aging

Sunday, May 3, 2026 · from 6 podcasts, 8 episodes
  • David Sinclair launches human trials to reverse cellular aging, using OSK genes to attempt blindness reversal.
  • AI screens billions of molecules for an affordable ‘age reversal pill’ that could prove reversal within months.
  • Sinclair’s ‘Friends of Sinclair Lab’ model raises $6M to bypass slow, risk-averse NIH grants.

David Sinclair is days away from injecting genes into a human eye to turn back time. His Harvard lab will use a cocktail of three Yamanaka genes, OSK, in a glaucoma patient - the first human epigenetic reprogramming trial. If it works, the goal is a systemic reboot: mouse studies already show OSK reversed aging in brains, kidneys, and muscles.

Sinclair describes this as a Wright Brothers moment for biology. On Moonshots with Peter Diamandis, he argues aging has no physical law and says 2026 could be the year the world learns human age reversal is possible. The target isn’t just slowing decline; it’s resetting a cell’s identity to its youthful backup copy.

“David Sinclair’s lab is days away from the first human epigenetic reprogramming trial, using a subset of three Yamanaka genes (OSK) in the eye of a patient to cure blindness, following successful mouse and monkey trials.”

- Moonshots with Peter Diamandis

Gene therapies today cost $500,000 to $2 million. Sinclair wants a pill that costs pennies. His lab used AI to screen billions of molecules and already has a proof-of-concept cocktail that reversed skin cells from a 92-year-old to a 20-year-old state. He expects human trials within months via the HealthSpan XPRIZE.

Funding almost killed the project. Political friction at Harvard nearly shuttered Sinclair’s lab after NIH grants were cut. In response, Diamandis and Sinclair launched ‘Friends of Sinclair Lab,’ a private patronage model that raised $6 million from 70 individuals. Diamandis says this allows the lab to move from idea to experiment in weeks, not years.

Peter Attia, on The Peter Attia Drive, frames the challenge: human brains evolved for social survival, not processing complex data. Scientific tools like peer review are “prosthetics for objectivity” we need because we can’t trust our unassisted judgment. For radical longevity work, Sinclair’s private funding model circumvents a grant system Attia calls retrospective and risk-averse.

“Peter Diamandis initiated the ‘Friends of Sinclair Lab’ (FOSL) to provide private, direct funding to David Sinclair's research after his government grants, totaling $1-3 million annually, were cut. FOSL has since raised approximately $6 million in annual support from around 70 members.”

- Moonshots with Peter Diamandis

The timeline is aggressive. Sinclair believes we can reach ‘longevity escape velocity’ - where tech adds more than a year of life per year lived. His personal protocol includes resveratrol, NMN, metformin, and nattokinase, which he says reverses arterial plaque. But new data shifts the consensus: genetics may dictate 50% of lifespan, not 10%. That makes genomic sequencing a clinical necessity, not a curiosity.

If OSK works in the eye, the scope expands instantly. Sinclair’s lab is already testing it for ALS and macular degeneration. The bottleneck is no longer human hypothesis generation - AI can match it - but how fast we can run the experiments AI suggests.

Source Intelligence

- Deep dive into what was said in the episodes

#2492 - Ari ShaffirApr 30

  • Ari Shaffir says Austin based pastor Brian Hubbard convinced Texas Lieutenant Governor Dan Patrick to allocate $100 million for the state's ibogaine initiative by explaining its neuroregenerative properties and its potential to help veterans addicted to opiates.
  • Rogan and Shaffir discuss the 1970 Controlled Substances Act, asserting that Nixon-era drug scheduling created a 56-year cultural knowledge block that prevented proper reevaluation of substances like psilocybin and MDMA. They argue FDA-approved studies by MAPS and Johns Hopkins provided the scientific groundwork for psychedelic therapy.
  • Rogan and Shaffir claim Purdue Pharma and the Sackler family lied about the addictive potential of OxyContin, despite knowing it operated on the same pathway as heroin. They reference the Netflix series Painkiller and an opioid overdose death statistic.
  • Rogan and Shaffir discuss the 1982 Chicago Tylenol murders, an unsolved case where seven people died from cyanide-laced capsules, which led to the introduction of tamper-evident seals on consumer products. They mention a subsequent attempted extortion for $1 million.
  • Rogan claims the ceremonial weigh-in process now involves fighters rehydrating scientifically over several hours after an official morning weigh-in with doctors, which is safer but still part of a flawed system.
Also from this episode: (6)

Business (1)

  • Shaffir cites lawsuits showing Ford proceeded with the Pinto's production despite pre-production crash tests revealing a vulnerability where rear-end collisions could cause the gas tank to explode. He frames this as a cost-benefit analysis favoring payouts over a recall.

Corruption (1)

  • Rogan alleges Coca-Cola hired paramilitary death squads in Colombia and Guatemala to suppress unionization efforts at bottling plants, and that Dole historically used similar tactics as the American Fruit Company to eliminate leftist leaders threatening profits.

Sports (3)

  • Rogan and Shaffir argue weight cutting in MMA is sanctioned cheating that rewards dehydration skills over fighting ability, disproportionately harms women, and skews competition. They advocate for more weight classes and random weight checks to enforce fighting at natural weight.
  • Ari Shaffir describes a high-stakes Dominican pool hall in the Bronx where pros like Oscar Dominguez gamble for tens of thousands; the chaotic, sharking environment with constant yelling rattles players and forces some to use noise-canceling AirPods.
  • Ari Shaffir recommends Mike Caro's 1970s poker strategy book for its race-based tells, like an older white man re-raising rarely bluffing or Mexicans bluffing more on payday. He successfully used a double-cross bluff against a pro at the World Series based on one tell.

Psychology (1)

  • Rogan says John Hopkins University researchers like Bill Richards developed specific psychedelic therapy playlists for psilocybin sessions, which are available on Spotify and serve as a non-verbal safety net during trips.

#2491 - Brian SimpsonApr 29

  • Brian Simpson says red light therapy and a macular support supplement eliminated his need for reading glasses, though his vision is still imperfect in low light.
  • Simpson had a heart attack on Super Bowl weekend in Atlanta and received a stent. He joked with the surgeon during the procedure, which she did not appreciate.
  • Simpson argues wolves cannot be trained, unlike bears, lions, or tigers, citing a friend's escaped wolves that killed a neighbor's sheep.
  • Catnip triggers playful or euphoric behavior in about two-thirds of cats due to the compound nepetalactone, with effects lasting 5 to 15 minutes.
  • Coyotes have expanded into every U.S. state and major city, including New York and Chicago. Their populations increase when pack members go missing, as females have larger litters.
  • A Russian fox domestication experiment over 60 years bred silver foxes for tameness, resulting in dog-like behavior. Domesticated foxes can cost around $9,000.
  • Coastal bears like Kodiak bears grow larger due to access to salmon runs, which provide easy, abundant food. During a run, bears focus solely on salmon and ignore other potential prey.
  • Cardiothoracic surgeon Dr. Stephen Gundry argues nicotine is a powerful mitochondrial uncoupler and that a high-polyphenol diet can mitigate smoking's damage, citing long-lived smokers in blue zones. Critics strongly dispute this, noting smoking is a leading cause of premature death.
  • A standard cigarette contains 10-14mg of nicotine, but smokers absorb only 1-2mg. Nicotine pouches range from 2mg to 12mg or more per pouch, with absorption being slower but total dose potentially similar.
  • The U.S. cigarette market is worth about $76 billion annually. The oral nicotine market is around $6 billion but is projected to reach $50 billion by 2030.
  • The global nicotine replacement therapy market (patches, gum, lozenges) is valued at $3.1 billion and is predicted to reach $4.7 billion by 2034.
Also from this episode: (7)

Society (4)

  • Simpson's dog Marshall ate pounds of gravel after consuming spilled chicken food, requiring an overnight vet stay. The dog passed the rocks without surgery.
  • Simpson criticizes people who keep large, high-energy dog breeds like Cane Corsos or Blue Heelers in small apartments without providing adequate exercise.
  • Simpson plays the closed beta video game 'Deadlock,' a 6v6 third-person game with 34 characters where players earn in-game currency (Souls) to buy items and snowball advantages. Matches last 25 minutes to an hour.
  • Streamer T-Pain has an elaborate multi-room gaming setup with racing and flight simulators. Simpson speculates top streamers can earn at least $250,000 per month.

Psychology (1)

  • Simpson's cat Millie has behavioral issues from a traumatic past with other animals but is affectionate with him. She is difficult to groom and restrain.

Climate (1)

  • Florida's invasive python problem originated from a research facility damaged by a hurricane. Control efforts using robot rabbit lures failed because alligators, the snakes' natural predators, attacked the boxes instead.

Politics (1)

  • Congresswoman Ilhan Omar mistakenly read 'World War II' as 'World War 11' from a script during a hearing, a clip of which circulated online.

Essentials: Control Sugar Cravings & Metabolism with Science-Based ToolsApr 30

  • Andrew Huberman describes two parallel neural circuits driving sugar consumption: one seeks sweet taste, while another seeks foods that raise blood glucose, both motivating sugar-seeking behavior.
  • Huberman states the hormone ghrelin increases with time since the last meal, making us hungry by acting on neurons in the arcuate and lateral hypothalamus.
  • Huberman states fructose, unlike glucose, cannot directly access the brain and must be converted in the liver, a process that reduces hormones that suppress ghrelin and increases hunger independent of calorie intake.
  • Huberman claims high fructose corn syrup contains fructose concentrations of 50% or more, far exceeding the 1-10% typically found in fruit.
  • Huberman explains that neuropod cells in the gut, discovered by Diego Bohórquez, respond to sugar and send signals via the vagus nerve to the brain, creating subconscious sugar cravings independent of taste.
  • Huberman explains that ingesting sugar triggers dopamine release in the brain's mesolimbic reward pathway, which generates a sensation of wanting more rather than satiety.
  • Huberman says combining sugary foods with fiber or fat lowers their glycemic index, blunting the blood glucose spike and the associated dopamine signal that drives craving.
  • Huberman cites an unpublished approach where some people take 5 grams of glutamine daily in divided doses to blunt sugar cravings, noting it can cause gastric distress and is not advised for those with cancer.
  • Huberman states ingesting lemon or lime juice before, during, or after a meal can blunt the blood glucose response, partly through sour taste perception altering the brain's response to sweetness.
  • Huberman states cinnamon can lower blood glucose by slowing gastric emptying, but cautions against consuming more than a teaspoon daily due to its potentially toxic cumarin content.
  • Huberman calls berberine a potent glucose-lowering agent that caused him hypoglycemia on an empty stomach, placing it alongside metformin and glibenclamide as serious tools requiring medical consultation.
  • Huberman cites a Cell Reports study showing each sleep stage has a distinct metabolic signature and argues that sleep deprivation disrupts metabolism and increases appetite for sugary foods.
  • Huberman categorizes glycemic index foods as low (below 55), medium (55-69), and high (above 70), noting these measurements are typically taken when foods are consumed in isolation.

Why Even Some Democrats Hate California’s Billionaire Tax ProposalApr 29

Also from this episode: (11)

Business (4)

  • A California ballot initiative proposes a one-time 5% tax on the net worth of state residents who were billionaires as of January 1st, 2024.
  • Laurel Rosenhall notes the tax structure is unusual because it targets assets - including stocks, jewelry, and art - instead of income. Residential property is specifically exempted.
  • Proponents, led by the SEIU-UHW union, say the tax revenue is needed to offset federal Medicaid and Obamacare subsidy cuts signed by Trump. The union trained volunteers to gather signatures.
  • Several high-profile billionaires relocated or changed their official residency ahead of the January 1st deadline, including Google co-founders Sergey Brin and Larry Page, and investors David Sacks and Peter Thiel.

Politics (7)

  • The measure qualified for the November ballot after gathering 1.5 million signatures. Polling shows over half of California voters and more than 70% of state Democrats support it.
  • Opponents argue the tax is unconstitutional because it is retroactive and would devastate California's innovation economy. Governor Gavin Newsom opposes it, fearing a long-term loss of income tax revenue from wealthy departures.
  • Newsom frames his opposition around a state-specific wealth tax, arguing any wealth tax should be applied at the national level to avoid putting California at a competitive disadvantage.
  • Progressive Senator Bernie Sanders supports the measure, framing it as a necessary step to tax extreme wealth and help those with less, despite structural concerns.
  • Laurel Rosenhall concludes the fight demonstrates that taxing the rich is popular but exceptionally difficult to implement due to structural complexities and the influence of the wealthy.
  • A grand jury in North Carolina indicted former FBI Director James Comey on two felony counts for allegedly threatening President Trump through a social media post with arranged seashells.
  • King Charles III addressed Congress, characterizing the US-UK relationship as a strong partnership born from historical disputes, including the American Revolution's 'no taxation without representation' principle.

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251Apr 28

  • David Sinclair says emerging data shows GLP-1 drugs benefit the heart and brain beyond weight loss, but notes a rare but serious side effect: about 20,000-30,000 people in the US annually develop sudden blindness, called NAION.
  • Sinclair states that AI accelerates his lab's work exponentially, enabling drug design by screening billions of molecules and classifying millions of cells as young or old within minutes.
  • Sinclair cites his own father's health as evidence that lifestyle can override poor genetics, noting his Ashkenazi Jewish ancestors typically died in their 70s.
  • Sinclair argues mindset is a powerful longevity factor, citing a National Academy of Sciences study that found optimists live 15% longer than pessimists.
  • Sinclair explains his xenohormesis hypothesis: stressed plants produce polyphenols that signal adversity, activating longevity pathways like SIRT1. He recommends eating colorful vegetables like broccolini.
  • Sinclair says recent research challenges the old view that genetics determines only 10-15% of lifespan, suggesting the influence may be closer to 50%, but emphasizes at least half of lifespan remains under personal control.
  • Peter Diamandis frames genetics' role: lifestyle determines health for the first 70-80 years, genetics dominate from 80 to 110, and emerging therapeutics aim to overcome genetic limits.
  • Sinclair cites evidence that nattokinase is the most natural and powerful method to reverse atherosclerosis, while lowering LDL with drugs like PCSK9 inhibitors can also have reversal effects.
  • Sinclair details his lab's OSK gene therapy, showing it activates telomerase to lengthen telomeres and is being tested to reverse blindness from NAION, ALS, and macular degeneration in animal models.
  • Sinclair, prompted by his wife Serena, is now studying the mind-body connection, citing a paper showing brain nerve manipulation affects gut immunity and having a student research sensory nerve rejuvenation.
  • Sinclair advises investors in longevity biotech to prioritize team reputation and track record, cash runway, and clinical stage, noting capital deficiency is the number one cause of company mortality.
  • Sinclair references decades of work by Dr. Bhasin showing testosterone does not extend lifespan but prevents falls and supports metabolic health, while clarifying that hormone replacement for women is now considered safe.
  • Sinclair emphasizes the need to stress the body in an abundance-driven world, advocating for saunas, red light therapy, avoiding plastics, and improving indoor air and water quality.

David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250Apr 27

  • David Sinclair's lab is days away from the first human epigenetic reprogramming trial, using a subset of three Yamanaka genes (OSK) in the eye of a patient to cure blindness, following successful mouse and monkey trials.
  • The epigenetic reprogramming technology shows benefits across various tissues in mice, including brain age reversal, memory improvement, and positive effects on motor neurons (ALS models), immune system, muscle, kidney, liver, skin, and joints.
  • Current human trials for targeted gene therapies, using adeno-associated viruses (AAV) for OSK delivery, typically cost between $500,000 and $2 million per treatment, but Sinclair aims for widespread, affordable application.
  • The Sinclair Lab developed a small molecule cocktail using AI screening, achieving proof of concept in reversing skin cells from 92-year-olds to a 20-year-old state. This cocktail aims for human clinical trials within months, with potential costs of a few cents per pill at scale.
  • David Sinclair believes there is no biological or physical law limiting human lifespan, suggesting it's possible to live hundreds or thousands of years by repeatedly resetting cells, akin to how the Wright Brothers’ flight opened possibilities beyond early expectations.
  • Peter Diamandis initiated the 'Friends of Sinclair Lab' (FOSL) to provide private, direct funding to David Sinclair's research after his government grants, totaling $1-3 million annually, were cut. FOSL has since raised approximately $6 million in annual support from around 70 members.
  • Sinclair projects that age reversal in humans could be definitively proven as possible as early as 2026, marking a pivotal moment in longevity research.
  • David Sinclair's personal longevity protocol includes resveratrol (taken with oil for absorption), NMN, and glucose-lowering medications like metformin (1 gram daily) or berberine. He also takes nattokinase (10,000 units daily), which has shown to reverse arterial plaque.
  • Sinclair emphasizes dietary adjustments like a mostly vegan diet, avoiding processed carbohydrates, and significantly reducing alcohol consumption due to new data linking even one daily glass to smaller brain size. He monitors health with carotid ultrasounds, preferring them over radiation-emitting CT scans.
  • Maintaining social connections, reducing stress through practices like meditation, and ensuring adequate sleep are crucial for longevity, as loneliness and chronic tension accelerate aging and negatively impact biomarkers like blood pressure and cholesterol.

352 | Bing Brunton on Connecting the Connectome to the BodyApr 27

  • Sean Carroll introduces the connectome as the brain's wiring diagram, detailing how neurons connect, akin to an engineering schematic. Bing Brunton clarifies that a fine-grain connectome maps individual cells, while a mesoscale one maps brain areas, with no consensus on the required resolution.
  • Bing Brunton highlights that mapping a human connectome at the cellular level is technologically impossible currently, contrasting it with human connectomes that typically represent connections between brain areas. The human brain contains approximately 85 billion neurons.
  • Bing Brunton states that roughly half the cells in the brain are glia, not neurons, and are increasingly recognized as vital with their own dynamics, not just support. This represents an exciting, emerging neuroscience field.
  • Bing Brunton emphasizes macroscopic organisms involve complex teamwork between cells and non-cellular substances, like bone, which is a living, vascularized structure. This highlights biology's inherently messy, interconnected nature.
  • The connectome is more than just a neuron connectivity matrix; it includes crucial information about cell identities (e.g., dopamine, serotonin neurons) and context-dependent message reception. While detailed biophysical properties matter, not all are required for holistic animal models.
  • The first full connectome, mapped about 30 years ago, was of the C. elegans nematode worm, a millimeter-long organism with ~300 neurons. Bing Brunton notes that despite this map, its behavior is hard to understand due to significant non-neural chemical and mechanical communication.
  • Bing Brunton reports the full connectome of the Drosophila fruit fly, including brain and ventral nerve cord, was published within the last year or two. The brain has ~150,000 neurons, with an additional 22,000 in the ventral nerve cord.
  • Unlike C. elegans, the Drosophila connectome is potentially easier to interpret due to the fruit fly's larger size, jointed limbs, and specialized cell types, features shared with humans. Neurons can be exceptionally long, enabling rapid signal transmission from a toe to the brainstem.
  • Bing Brunton explains all animal locomotion, from walking to breathing, involves rhythmic movements generated by Central Pattern Generators (CPGs) within the nervous system. These circuits autonomously produce cyclic instructions, known since the 1910s, though specific cellular implementations for walking were unclear.
  • Bing Brunton's team, with John Tuthill, simulated a fruit fly ventral nerve cord (4,000 neurons controlling two front legs). A "pruning study" then identified a minimal circuit of just three neurons - two excitatory (E1, E2) and one inhibitory (I1) - sufficient to generate the basic walking rhythm.
  • Brunton highlights a successful model-driven prediction: a previously unstudied neuron from the central brain made a fly leg tap when activated by a laser. Experimental validation confirmed this prediction, demonstrating the model's predictive power beyond simply fitting existing data.
  • Bing Brunton's lab aims to create "digital twins" of animals: biologically interpretable simulations of the nervous system within a biomechanically realistic body and virtual environment. This allows studying complex feedback loops and predicting behaviors human intuition cannot grasp.
  • Brunton critiques "digital sphinx" models achieving behavioral fidelity without biological accuracy, demonstrating it by training a C. elegans connectome to control a fly body with reinforcement learning. This shows deep learning can mimic behaviors even with mismatched neural architectures, emphasizing meaningful biological interfaces.
  • Bing Brunton suggests understanding the nervous system's embodied nature, evolved to control a body for sensory-motor functions, is crucial for comprehending higher cognitive functions like consciousness. She notes all agreed-upon intelligent, conscious agents are embodied.
  • Brunton envisions using embodied animal models to understand nervous and musculoskeletal system interactions, especially for injuries like spinal cord damage. Such models could provide insights into long-term adaptations and help design better therapeutics or rehabilitation strategies.

#389 - Thinking scientifically: why it's hard, why it matters, and a practical toolkitApr 27

  • Peter Attia aims to translate longevity science into accessible content, supported entirely by members to avoid reliance on paid advertisements.
  • Peter Attia cites smoking as a case where overwhelming evidence, including epidemiologic data and mechanistic understanding, makes the conclusion that smoking causes cancer nearly "true."
  • Dietary guidelines long held that dietary cholesterol directly raises blood cholesterol and cardiovascular risk; however, Peter Attia explains this simple causal chain was incomplete and the relationship is more complex.
  • Peter Attia uses detox cleanses as an example of process failure, where marketing jumps from a real problem to a solution without specific hypotheses, mechanisms, or controlled studies to validate the cause.
  • Peter Attia warns that "third-party tested" for supplements often means only checking for heavy metal contamination, not verifying active ingredient content, which can falsely reassure consumers about product quality.
  • In the 1840s, Ignaz Semmelweis found childbed fever mortality in the doctor's clinic was five times higher than in the midwife clinic at Vienna General Hospital. Mortality dropped from 18% to under 2% after doctors washed hands with chlorinated lime.
  • Peter Attia cites Kary Mullis, a Nobel laureate in chemistry, who denied HIV caused AIDS, influencing early 2000s South African policy and potentially leading to over a quarter-million deaths.
  • Peter Attia advises caution towards those who claim to be always right while everyone else is wrong, noting that scientific progress involves becoming "less wrong" over time. Past errors, like the egg-cholesterol link, demonstrate the system's self-correction.
Also from this episode: (19)

Psychology (10)

  • Peter Attia defines scientific thinking as a skill for evaluating claims and updating beliefs based on evidence, emphasizing a continuous process of becoming "less wrong over time."
  • Scientific thinking involves generating hypotheses, testing them against evidence, and updating beliefs while tolerating uncertainty and separating desire from truth. Richard Feynman's principle warns against self-deception.
  • Peter Attia advises treating personal certainty as a signal to pause and question beliefs, as certainty is a feeling, not a truth indicator. If belief stems from social consensus or identity, it’s a red flag.
  • Peter Attia instructs individuals to judge the *process* behind a claim, not just its conclusion, by asking how evidence was gathered and alternatives considered. A sound process is crucial for reliable conclusions.
  • Coalitional thinking, deeply wired into human cognition, can override scientific reasoning by letting group identity dictate beliefs. Peter Attia stresses the need to evaluate arguments on their merits, independent of their source or group affiliation.
  • Peter Attia suggests evaluating how experts use jargon: explaining to inform versus performing to impress. Legitimate use adds precision, while hiding behind jargon may indicate an attempt to mislead.
  • When evaluating experts, Peter Attia suggests checking if they demonstrate their reasoning, engage with disagreements fairly, and anchor their opinions to data. Richard Feynman stated, "If it disagrees with experiment, it's wrong."
  • Peter Attia emphasizes that trustworthy experts acknowledge uncertainty and have publicly changed their minds, indicating a greater commitment to accuracy than to maintaining an infallible image.
  • Peter Attia identifies financial incentives as a red flag, warning that if an expert primarily profits from selling products or generating engagement through contrarianism, their interests may not align with truth or well-being.
  • Peter Attia defines scientific consensus as an overwhelming body of evidence leading qualified experts to the same conclusion, giving it a high prior probability of accuracy. Challenging consensus requires new data, not ideology or "vibes."

Science (8)

  • Peter Attia argues "I don't know" and "it depends" are often the most honest scientific answers, noting science primarily functions by ruling things out and iteratively reducing error over time.
  • Science relies on models that are approximations, not absolute proofs, which exist only in formal logic. Peter Attia states we gain confidence in explanations that withstand data, progressively ruling out alternatives.
  • Newtonian gravity, first proposed by Isaac Newton in 1887, was refined by Einstein's theory that gravity bends time and space, exemplified by GPS satellite clocks adjusting 38 microseconds daily. This prevents misalignments of 8 meters per minute.
  • Scientific thinking is unnatural because human brains evolved over 50 million years for social survival, where group acceptance was paramount. Formal logic and empiricism are far more recent developments, making social cognition often override logical thought.
  • Peter Attia highlights that scientific institutions have "invented" corrective tools such as peer review, blind experiments, and statistical frameworks to counteract natural human biases. Double-blind trials, for instance, explicitly account for inherent bias.
  • Peter Attia warns against confusing criticism with understanding, noting it's vastly easier to criticize a study than to design one. Brandelini's Law states refuting "bullshit" requires significantly more effort than creating it.
  • Peter Attia recommends carefully outsourcing thinking by building a "personal board of advisors," recognizing no individual can be an expert across all domains. He suggests evaluating experts' true expertise, credentials, and track record.
  • Peter Attia concludes that scientific thinking involves noticing when certainty and identity mislead, judging the quality of a process, and carefully choosing who to trust. The goal is improved calibration, judgment, and adaptability.

History (1)

  • Peter Attia recalls Galileo's heliocentric model, which was rejected not on scientific grounds but because it threatened the identity and authority of the church, demonstrating the power of identity-based resistance to evidence.